Senti Bio

Private Company Communications

 

Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary combinations of DNA sequences, to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments.

Red House partnered with Senti Bio’s leadership team to amplify a highly successful $105M Series B announcement.

Red House led content development and media engagement including liaising with investors. Media outreach led to more than a dozen articles and reached over 100K followers on Twitter and LinkedIn.

Senti Bio Case Study

 

Media Outreach and Results

  • Embargo outreach: 12 reporters

  • Interviews secured: 5

  • Full coverage articles: 9

  • Roundup articles, wire coverage, mentions: 4

Coverage

  • Full coverage: Endpoints, TechCrunch, Timmerman Report, Fierce Biotech, BioCentury, SF Business Times, Tech Startups, BioSpace, BioPharma Dive

  • Mention/Roundup: Crunchbase, Fortune TermSheet, Silicon Valley Business Journal, BioWorld

 

“Denise, Kelli and the team have been a fantastic group to partner with in building and telling the Senti Bio story over the past couple of years. They feel like true team members, integrated into all of the business, and operate as thought partners for us on the path toward becoming a public company and translating our gene circuit therapies into the clinic for cancer patients in need.”

— Curt Herberts, former Senti Bio COO.

Previous

Translate Bio Case Study